AI assistant
Burberry Group PLC — Board/Management Information 2019
Feb 6, 2019
4822_rns_2019-02-06_47abaa9a-4afa-4fb2-99e3-a342be81475d.html
Board/Management Information
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 3008P
Burberry Group PLC
06 February 2019
6 February 2019
BURBERRY GROUP PLC
BOARD COMMITTEE CHANGES
Burberry Group plc (the Company) today announces that Jeremy Darroch has decided to step down as Chairman of the Audit Committee with effect from 6 February 2019. Jeremy will remain on the Board as Senior Independent Director and as a member of the Audit and Nomination Committees.
Matthew Key, who has been a member of the Audit Committee since 26 September 2013, will succeed Jeremy as Chairman of the Audit Committee, with effect from 6 February 2019.
There are no other changes to Committee memberships.
This announcement is made in accordance with LR 9.6.11 (3)
Enquiries
| Investors and analysts | ||||
| Annabel Gleeson | Director, Investor Relations | 020 3367 4458 [email protected] |
||
| Media | ||||
| Andrew Roberts | VP, Corporate Relations | 020 3367 3764 [email protected] | ||
Notes to editors
· Burberry is a global luxury brand with a distinctly British attitude.
· At 29 December 2018, globally Burberry had 237 retail stores, 151 concessions, 52 outlets and 46 franchise stores, excluding the impact of pop up stores.
· Burberry, is listed on the London Stock Exchange (BRBY.L) and is a constituent of the FTSE 100 index. Its ADR symbol is OTC:BURBY.
· BURBERRY, the Equestrian Knight Device, the Burberry Check and the Thomas Burberry Monogram and Print are trademarks belonging to Burberry.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
BOAUNSNRKKAURAR